Juvit

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Juvit

Property Description
Active Ingredient Sodium Ascorbate
Form Oral Drops (Solution)
Pharmacological Class Water-Soluble Vitamin / Nutrient Supplement
General Purpose Essential Vitamin C Supply
Origin Derived (Sodium salt of L-Ascorbic Acid)

Juvit: Classification and Active Component Identity

Juvit is a brand of medicinal preparation defined by its core active ingredient, Sodium Ascorbate, and is formally classified as a Water-Soluble Vitamin and a Nutrient Supplement within the broader Pharmacological Class of essential vitamins. The active compound is chemically the monosodium salt of L-Ascorbic Acid, which is the biologically active form commonly known as Vitamin C. Humans cannot synthesize this vitamin internally, making it an essential dietary component. This product is often available as an Over-The-Counter (OTC) drug and is primarily positioned for pediatric use. The use of the salt form, a mineral ascorbate, is a key feature clinically recognized for its lower acidity compared to pure Ascorbic Acid formulations, which contributes to better gastrointestinal tolerance, especially in infants.

Composition, Form, and General Purpose

This preparation is a single-ingredient formulation supplied as Oral Drops (Solution), an aqueous, liquid format specifically designed for the Oral Route of Administration. This particular form allows for ease of administration and accurate measurement, which is beneficial when supplementing infants and young children. The fundamental purpose of the preparation is to ensure the adequate nutritional supply of this essential vitamin to the body. Vitamin C is necessary for the biosynthesis of collagen, L-carnitine, and certain neurotransmitters. The high-level purpose of the preparation is reflected in its role as a potent antioxidant that helps protect cells from oxidative damage, a mechanism that is supported by pharmacological studies.

Regulatory References

  1. MedlinePlus Vitamin C

What side effects are possible with Juvit?

Possible side effects and safety information

The safety profile for this preparation is structured by regulatory documents to address potential effects categorized by frequency, affected system, and specific population risk.

Adverse Reactions by System-Organ Class

The most commonly reported adverse reactions are related to the Gastrointestinal System, often manifesting as diarrhea, nausea, vomiting, or stomach cramps. These effects are generally associated with intakes exceeding 2, g daily, as noted in official regulatory information. The Nervous System may also be affected, with documented effects including headache, fatigue, and difficulty sleeping.

Less frequent but important reactions involve the Skin and Immune System, including various forms of hypersensitivity reactions such as exanthema or urticaria.

Serious Adverse Reactions and Population-Specific Risks

Official labeling documents address specific serious risks, particularly those related to metabolism and pre-existing conditions. These include the risk of developing oxalate kidney stones (nephrolithiasis) and, in severe cases, oxalate nephropathy, which are formally classified as very rare outcomes, primarily following prolonged use of high doses.

A critical safety consideration is for individuals with Glucose-6-phosphate dehydrogenase (G6PD) deficiency, who are at risk of severe hemolysis (destruction of red blood cells). This is a well-documented population-specific risk noted in official safety information. Furthermore, patients with renal impairment or a history of kidney stones must be considered due to the compound’s metabolic pathway.

Safety-Related Restrictions

The strong reducing capacity of the compound can lead to interference with laboratory tests, potentially causing false results for certain parameters, such as blood and urine glucose or nitrite levels, a limitation documented in the official safety profile.

Overdose and Emergency Response

The official regulatory profile for an overdose of Juvit (Sodium Ascorbate) focuses on the potential for organ toxicity and specific risk factors, based on documented evidence from government health authorities.

Documented Manifestations and Severe Outcomes

Documented manifestations from ingestion of large or prolonged high doses may include gastrointestinal disturbances such as diarrhoea and the formation of renal oxalate calculi (kidney stones). More severe outcomes listed in regulatory documents include the development of acute or chronic oxalate nephropathy, which carries the potential for renal failure. In susceptible individuals, there is a documented risk of severe hemolysis (destruction of red blood cells).

When Immediate Medical Help is Required

Urgent medical attention is required for any signs of severe overdose, particularly intense side or lower back pain (suggesting renal issues) or confirmed severe hemolysis or oxalate nephropathy. The official prescribing information mandates that if these severe outcomes are suspected or confirmed, the product must be discontinued, and management should focus on symptomatic and supportive treatment. No specific antidote is known, according to regulatory labels.

Population-Specific Overdose Notes

Specific patient populations are documented to be at increased risk of severe outcomes. Individuals with Glucose-6-phosphate dehydrogenase (G6PD) deficiency face an elevated risk of severe hemolysis. Patients with pre-existing renal impairment, those with a history of kidney stones, geriatric patients, and pediatric patients under 2 years are identified in regulatory labeling as having increased susceptibility to oxalate nephropathy. Regulatory documents require the monitoring of renal function and blood counts in these high-risk groups.

Therapeutic Uses of Juvit

Juvit (Sodium Ascorbate) is commonly used for managing and providing support for symptomatic Vitamin C deficiency states. The nutrient is relevant for conditions where additional symptomatic support is needed.

This preparation is applied in addressing conditions marked by deficiency, including the acute episodes of scurvy, along with the symptoms of connective tissue fragility, impaired tissue repair, and systemic weakness that characterize the deficiency. It is commonly used across conditions presenting with acute episodes and relevant in contexts involving heightened systemic burden, such as during postoperative convalescence or when managing malabsorption issues.

“It contributes to easing the overall symptom load and supports patients during episodes of heightened discomfort.”

The use of this supplement may assist with managing symptoms related to physical discomfort, such as bleeding gums and easy bruising. It helps patients cope more steadily with symptom fluctuations, providing supportive relief when deficiency symptoms interfere with routine activities and functional stability.

Quick Fact: Support for Systemic Symptoms Juvit is commonly used to help with symptoms related to systemic imbalance, including fatigue, lethargy, and generalized weakness. This assists with maintaining functional stability during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus information

Eligibility and Restrictions for Use

Who Can and Cannot Use Juvit

The eligibility for Juvit (Sodium Ascorbate) is strictly defined by official regulatory labeling, focusing on specific population groups and health conditions.

Populations Contraindicated

The medicine is absolutely contraindicated for individuals with a known hypersensitivity or allergy to Sodium Ascorbate or any component of the formulation. High-dose use is also restricted or cautioned against in patients with certain blood disorders, including thalassemia, sickle cell disease, and hemochromatosis, as stated in regulatory summaries.

Age-Specific Eligibility

Juvit is generally suitable for the adult and adolescent population. Its Oral Drops formulation is primarily intended for pediatric use, with deficiency treatment protocols established for infants aged 5 months and older. Although eligible, geriatric patients may be at an increased risk of complications associated with higher intakes.

Conditional and Restricted Use

Use is subject to limitations based on coexisting conditions:

  • G6PD Deficiency: Patients must not exceed the official Recommended Dietary Allowance (RDA) to mitigate the risk of severe hemolysis.
  • Renal Risk: Individuals with renal impairment or a history of oxalate kidney stones are documented as being at an increased risk of oxalate nephropathy, requiring caution.
  • Maternal Status: Pregnant and lactating women are restricted to not exceed the RDA or Adequate Intake (AI) established for their condition.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Juvit (Sodium Ascorbate) primarily through its capacity to influence the absorption and exposure of other substances, along with specific pharmacodynamic effects.

Documented Pharmacokinetic and Pharmacodynamic Interactions

Co-administration with Warfarin and other coumarin anticoagulants has been formally documented to lead to a reduced therapeutic effect of the anticoagulant, an outcome detailed in regulatory prescribing information. The presence of Juvit officially increases the absorption of elemental iron from the gastrointestinal tract, resulting in greater systemic exposure to iron. This enhancement of absorption necessitates caution when the product is used alongside iron supplements.

Interaction-Related Restrictions and Constraints

There is a specific, officially documented pharmacodynamic interaction involving Deferoxamine. Co-administration is described as impairing cardiac function and precipitating cardiac toxicity, an effect noted particularly in patients with chronic iron overload. Regulatory labels also state that this product may enhance the absorption of aluminum from aluminum-containing antacids, leading to a mandated separation of administration time between the two substances.

Furthermore, official data indicate that co-administration may increase the plasma concentrations of estrogen components found in oral contraceptives. A population-specific consideration noted in regulatory summaries is the risk of oxalate accumulation and nephrolithiasis (kidney stones) in patients with renal impairment when higher doses are used.

Mechanism of Action

The function of Sodium Ascorbate, L-Ascorbic Acid, is defined by its role as an essential biological cofactor and a ubiquitous electron donor. Its primary mechanistic domain involves functioning as a reducing agent for Fe^2+-dependent hydroxylase enzymes. By maintaining the reduced, active state of these enzymes, the molecule directly enables the post-translational modification of procollagen, which is the required biochemical step for forming the stable, triple-helical structure of collagen. This cascade establishes the structural basis for blood vessel walls and connective tissues. The secondary, widespread action is as an antioxidant, where the molecule rapidly donates electrons to scavenge Reactive Oxygen Species (ROS) and free radicals in the aqueous cellular environment. This reduces oxidative damage to molecular structures and thereby maintains the functional state of cells. Additionally, Ascorbate acts as a cofactor for enzymes like dopamine beta-hydroxylase, influencing norepinephrine synthesis, and pathways required for cellular energy metabolism via L-carnitine synthesis.

Dosage and Administration Information

The administration of Juvit, a preparation containing Sodium Ascorbate, is exclusively through the oral route as it is supplied in an Oral Drops (Solution) dosage form. This liquid solution is intended to be swallowed.

Administration Scope

Instruction Detail
Route of administration Oral (by mouth).
Dosing schedule Deficiency Treatment (Adults): Typically 500 mg daily for a minimum course of two weeks. Maximum daily intake is generally restricted to 2,000 mg. Routine Supplementation: Lower doses, typically taken once daily.
Timing in relation to meals (if applicable) The drops may be delivered directly or taken mixed with cereal, fruit juice, or other food.
Preparation requirements (if applicable) Administered either directly into the mouth or by mixing into an appropriate food or liquid.
Age-group administration rules Infants (7–12 months): 50 mg per day is the daily intake allowance. Treatment doses for children typically range from 100 to 300 mg a day for the minimum course duration.
Missed-dose rules If a dose is missed, individuals should skip the missed dose if it is almost time for the next scheduled dose and not take a double dose.
Special procedural conditions The use of the preparation follows a defined course duration for deficiency correction.

Instruction Classifications (High-Level)

Classification Detail
Administration method type Oral
Frequency pattern Daily (once daily or in divided doses for treatment)
Basis of guidelines Standard nutritional and health frameworks
Use-context constraints Administration must adhere to fixed dose and frequency rules defined for either routine supply or time-bound deficiency treatment.

Resulting Procedural Structure

Official step sequence:

  • Administer the liquid drops solution by mouth.
  • Measure the prescribed dose amount.
  • The dose may be delivered directly or mixed with a food or liquid.
  • Follow the scheduled frequency, which may be once daily or in divided doses depending on the regimen.
  • If a dose is missed, do not take two doses to compensate.

Connection to the overall use protocol: The official instructions establish a standardized protocol for administering the correct dose via the oral route, ensuring adherence to established requirements. This structure defines the precise frequency, time-bound duration, and preparatory steps, providing a neutral framework for how the product must be used without crossing into safety or clinical decision-making.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Juvit

The body of research for the active ingredient in Juvit, Vitamin C (as Sodium Ascorbate), primarily focuses on its essential role in human nutrition and its ability to address states of deficiency. The evidence summarized here is derived from regulatory records, historical observations, clinical case reports, and modern scientific reviews.


Evidence for Use in Severe Deficiency (Scurvy)

The evidence for Vitamin C's role in addressing severe deficiency is historically established in the research record. Research in this area has primarily involved classic intervention studies and contemporary observational settings. Outcomes measured included the time until the changes in visible clinical signs (such as bleeding gums and skin lesions) and the eventual increase in low ascorbic acid blood levels. Findings from these historical and observational studies describe patterns associated with changes in deficiency manifestations and the correction of the underlying biochemical imbalance.

Evidence for Use in Marginal Deficiency States

Research has also examined populations with lower-than-adequate Vitamin C blood levels (marginal deficiency or hypovitaminosis C). Studies explored how supplementation was associated with a shift in blood levels, monitoring the outcome of achieving adequate plasma concentration. Other research has explored whether increasing Vitamin C levels relates to changes in non-specific symptoms, such as fatigue or outcomes related to systemic imbalance. Findings regarding the improvement in non-specific symptoms were mixed across different trials.

What Remains Uncertain in the Research Record

While the evidence related to correcting frank scurvy is well documented in research, studies exploring broader uses of Vitamin C have some limitations. For instance, in supportive care settings (e.g., critical illness), findings related to major clinical endpoints, such as outcomes related to hospital duration or survival, were inconsistent and varied considerably among different trials. Additionally, long-term effects on functional stability over many months or years are generally not well characterized by the existing studies, as follow-up durations were typically limited.

Key Studies & References

  1. Vitamin C - Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids - NCBI Bookshelf
  2. Vitamin C Deficiency - Symptoms, diagnosis and treatment | BMJ Best Practice US
  3. Vitamin C: MedlinePlus Medical Encyclopedia
  4. SODIUM ASCORBATE (Juvit equivalent) - Philippine FDA Verification Portal

Frequently Asked Questions (FAQ)

Common questions about Juvit (FAQ)


Q: Can Juvit be taken at night?

Official product information suggests that difficulty sleeping or insomnia is a documented potential adverse reaction associated with this class of compound. Individuals may consider the timing of their dose in relation to this possible nervous system effect. Concerns about changes in sleep patterns may be discussed with a healthcare provider.


Q: Do I need a prescription to get Juvit?

The active ingredient in Juvit is a form of Vitamin C, which is widely used as a dietary supplement and is often available Over-The-Counter (OTC). However, high-strength versions or specific formulations may be regulated as prescription-only drugs. The requirements for obtaining the product can vary based on the specific strength or formulation.


Q: How quickly does Juvit usually start to work?

In cases of deficiency, studies indicate that clinical improvement—such as the correction of symptoms like fatigue—is typically observed within the first one to two weeks of beginning a daily administration regimen. For routine supplementation, the intent is to support immediate and ongoing maintenance of the nutrient supply.


Q: Is Juvit a controlled substance?

No. Official regulatory schedules confirm that the active ingredient in Juvit, Sodium Ascorbate, is classified as a water-soluble vitamin and nutrient supplement. It is not classified as a controlled substance under federal drug laws.


Q: Does Juvit interact with common pain relievers?

General drug interaction databases typically do not report a major or clinically significant interaction between the active ingredient in Juvit (Ascorbic Acid) and common pain relievers like Acetaminophen or NSAIDs. All medications and supplements should be reviewed by a healthcare professional when considering combination use.


Q: Is it necessary to avoid caffeine while taking Juvit?

Official interaction checkers generally do not list a direct interaction between the active ingredient and caffeine. However, since Juvit is a form of sodium ascorbate, individuals following a sodium-restricted diet should be mindful of combining high doses with other sources of sodium.


Q: Can I take Juvit with my vitamin supplements?

Caution is noted when combining Juvit with supplements containing elemental iron, as official documents indicate that Juvit increases the absorption of iron from the gut. Interactions with other common vitamins are generally not documented as clinically significant.


Q: Are there any known food interactions with Juvit?

The official administration instructions confirm that Juvit Oral Drops can be taken by mouth, either directly or mixed with food, cereal, or fruit juice. While no specific foods are strictly prohibited, individuals on a sodium-restricted diet may need to consider the sodium content of this formulation.


Q: Is Juvit safe for older adults (seniors)?

The product is generally used by older adults, though official information indicates specific considerations for this population. Geriatric patients may have an increased risk of complications associated with higher intakes, such as the formation of oxalate kidney stones. Intake levels should align with individual needs and established guidelines.


Q: What should I do if I feel dizzy after starting Juvit?

Dizziness has been documented as a possible adverse effect in medical literature, particularly with high-dose use, though it is not common for standard oral doses. All new or persistent symptoms may be discussed with a healthcare provider.


Q: Can Juvit impact appetite?

Loss of appetite (anorexia) is a symptom associated with the severe deficiency that Juvit is intended to treat. However, regulatory documents for standard use do not list appetite change as a common adverse reaction.


Q: What is the maximum recommended time to use Juvit?

High-dose use for deficiency treatment is limited to a defined course. For routine supplementation, the product is intended for long-term use within the Recommended Dietary Allowance (RDA) levels, but official research summaries indicate that long-term safety beyond the established nutrient intake limits is not well-characterized.


Q: What are the warning signs mentioned in the official Juvit pamphlet?

Official safety labeling includes warnings about the risk of oxalate kidney stones (nephrolithiasis) and the potential for severe hemolysis (red blood cell destruction) in patients with a specific enzyme deficiency (G6PD deficiency), particularly when using high doses. These are serious, documented risks.


Q: Does Juvit contain any stimulants?

No. The active ingredient in Juvit is Sodium Ascorbate, which is formally classified by regulatory agencies as a water-soluble vitamin and nutrient supplement. It does not contain or function as a pharmaceutical stimulant.


Q: Are there any known effects of Juvit on the liver?

While the liver is involved in the active ingredient's metabolism, regulatory adverse reaction sections do not list adverse effects on liver function as a common or serious risk associated with general use of the product.


Q: Are there different strengths or forms of Juvit?

The Juvit product is specifically supplied as Oral Drops (Solution), which is a liquid format. However, various strengths of the active ingredient (Ascorbic Acid) are widely available across different branded and generic products in the market.


Q: Is it important to take Juvit consistently every day?

The official established dosing schedules for both deficiency treatment and routine supplementation are defined as daily administration. Consistency is necessary to help the body maintain adequate levels of this essential nutrient.

How should Juvit be stored and disposed of?

How to Store and Dispose of Juvit?

The required storage and disposal of Juvit (Sodium Ascorbate Oral Drops) are defined by official labeling to preserve the medicine's chemical stability and ensure safety.

Required Storage Conditions

  • Temperature: Store at controlled room temperature, specifically between 15 C and 30 C (59 F and 86 F). The product must be protected from freezing.
  • Light Protection: The container must be stored away from direct light to maintain the stability of the solution and be closed tightly after each use.
  • Child Safety: The medicine must be stored out of the reach of children.

Disposal Instructions

  • Preferred Method: Disposal of unused or expired product should prioritize a drug take-back program or an authorized mail-back envelope.
  • Household Trash: If a take-back program is unavailable, the liquid contents must be mixed with an undesirable substance (such as used coffee grounds) before being sealed in a container and placed in the trash.
  • Environmental: Do not flush the medicine down the sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Juvit found in:

A-Z Index: